Filter
1698
Filtered Results: 1698
Text search:
adverse
reactions
Featured
Recommendations
202
New Publications
465
Language
Document type
No document type
1011
Guidelines
302
Studies & Reports
175
Manuals
103
Strategic & Response Plan
35
Fact sheets
34
Training Material
21
Situation Updates
6
Brochures
4
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
111
South Africa
50
Global
43
Ethiopia
39
Western and Central Europe
39
Nigeria
37
Kenya
37
Tanzania
30
Uganda
29
Nepal
28
Latin America and the Carribbean
25
Zambia
24
Malawi
22
Ghana
21
Sierra Leone
19
Philippines
18
Africa
17
Eastern Europe
17
Liberia
16
Bangladesh
16
Zimbabwe
13
Rwanda
13
Namibia
13
Cambodia
12
Myanmar / Burma
12
South–East Asia Region
12
Indonesia
10
Ukraine
9
Eswatini/ Swaziland
8
Botswana
8
Lesotho
8
Congo, Democratic Republic of
7
USA
7
Asia
6
Senegal
5
Syria
5
Colombia
5
East and Southern Africa
5
Middle East and North Africa
5
South Sudan
4
Germany
4
Brazil
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Haiti
3
Thailand
3
Mozambique
3
Argentina
3
Western Pacific Region
3
Moldova
3
Guinea
2
Cameroon
2
Afghanistan
2
Lebanon
2
Benin
2
Ecuador
2
Bolivia
2
Sri Lanka
2
Bhutan
2
Venezuela
2
Timor Leste/ East Timor
2
Russia
2
Burkina Faso
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Somalia
1
Pakistan
1
Iraq
1
Gambia
1
China
1
Ireland
1
Libya
1
Angola
1
Madagascar
1
Chile
1
Yemen
1
Other region
1
Paraguay
1
Fiji
1
Solomon Islands
1
Palestine
1
North Korea
1
Laos
1
Tajikistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Vietnam
1
North America
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
596
Clinical Guidelines
244
Public Health
82
Women & Child Health
63
Key Resources
50
Capacity Building
29
Pharmacy & Technologies
25
Toolboxes
TB
172
Mental Health
151
COVID-19
137
HIV
106
Pharmacy
88
NTDs
65
Rapid Response
51
AMR
43
Ebola
40
Planetary Health
39
Caregiver
36
Refugee
26
NCDs
26
Conflict
24
Specific Hazards
22
Polio
19
Zika
16
Disability
11
Cholera
10
Natural Hazards
10
Global Health Education
9
Health Financing Toolbox
3
Treating the Patient with Tuberculosis
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T...
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T...
Draft for consultation
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
